Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.
Open Access
- 1 November 1993
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 92 (5) , 2131-2140
- https://doi.org/10.1172/jci116814
Abstract
We have evaluated the contribution of depression of individual procoagulant vitamin K-dependent clotting factors to the ability of warfarin to protect rabbits against tissue factor-induced coagulation. Mean activities of individual procoagulant factors were determined, in assays with rabbit substrates, for a group of rabbits achieving a protective degree of anticoagulation with warfarin. Values were: factor VII, 12%; factor IX, 7%; factor X, 14%, and prothrombin, 13%. The effect upon tissue factor-induced coagulation of selective immunodepletion of each factor to a comparable level was then evaluated. Immunodepletion of plasma factor X or prothrombin, but not of factor VII or factor IX, protected otherwise normal rabbits against tissue factor-induced coagulation. Next, we determined the effect upon the protection in warfarin-treated rabbits of selectively restoring factor X or prothrombin before infusing tissue factor. When either factor was selectively restored, warfarin's protective effect was abolished. Moreover, selective restoration of prothrombin sensitized warfarin-treated rabbits to coagulation more severe than observed in nontreated control rabbits. One may extrapolate from these data that depression of both factor X and prothrombin are required for warfarin's clinical antithrombotic efficacy and that depression of plasma prothrombin is particularly important.Keywords
This publication has 30 references indexed in Scilit:
- A sensitive, accurate assay for extrinsic pathway inhibitor (EPI) activity in rabbit plasma: Paradoxical effect of excess exogenous factor XThrombosis Research, 1990
- RANDOMIZED PROSPECTIVE TRIAL COMPARING THE NATIVE PROTHROMBIN ANTIGEN WITH THE PROTHROMBIN TIME FOR MONITORING ORAL ANTICOAGULANT-THERAPY1990
- The effect of sodium warfarin on rabbit monocyte tissue factor expressionThrombosis Research, 1986
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- SURGERY IN PATIENTS WITH CONGENITAL FACTOR VII DEFICIENCY (CONGENITAL HYPOPROCONVERTINEMIA). EXPERIENCE WITH ONE CASE AND REVIEW OF THE LITERATURE.1965
- A clinical and family study of hereditary proconvertin (factor VII) deficiencyThe American Journal of Medicine, 1964
- Behaviour of Factors II, VII, IX, and X during Long-Term Treatment with CoumarinThrombosis and Haemostasis, 1963
- Factor VII: its Turnover Rate and its Possible Role in ThrombogenesisThrombosis and Haemostasis, 1960
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957